Pre-operative Epirubicin, Capecitabine (Xeloda) and Cisplatin in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma
Sponsor study identifier
interventional
80
1 country
1
Study Start
November 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedTo investigate the efficacy and safety of epirubicin, cisplatin and capecitabine as neoadjuvant therapy prior to radical resection in patients with newly diagnosed operable oesophageal adenocarcinoma.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2002
Date type not reportedThis date has not been verified as actual or estimated.
September 19, 2005
Actual (reported)September 22, 2005
Actual (reported)Pathological complete response rate
Progression free survival
Overall survival
Objective response rate assessed by CT and EUS
Treatment related toxicity including peri-operative complications
Time to improvement of dysphagia
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
epirubicin, capecitabine, cisplatin
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordRoyal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom
David Cunningham
Royal Marsden NHS Foundation Trust
First Submitted
September 19, 2005
First Posted
September 22, 2005
Study Start
November 2002
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
December 16, 2009
Record last verified: 2009-12
Contact the study team to confirm eligibility.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: